Genetic Toxicology
Genetic Toxicology is the branch which deals with the study of the damages to the genes by means of chemical or Physical factors. Most of the damages to the genetic materials such as DNA and RNA are mostly repaired, if the process had a faulty mechanism in repairing or the process is not functional timely and correctly, these changes or the damages cause mutations and might tend to alteration or deletion of a particular gene. This Genetic Toxicity is thus defined as the changes or the effects to the genetic material resulting in inheritable or mutational defects. Various changes include breakage of the Chromosomes (clastogenesis), mutagenesis, aneugenesis or recombinations are some of the possible changes that might be alter the Genetic Material.
- Genotoxicity and mutagenicity
- Genotoxic medication
- In vitro and in vivo testing
- Pharmacogenetics & pharmacogenomics
Related Conference of Genetic Toxicology
6th International Conference on Clinical Pharmacology and Toxicology
Genetic Toxicology Conference Speakers
Recommended Sessions
- Applications of Toxicology
- Cardiovascular Toxicology
- Chemical Carcinogenesis
- Clinical Toxicology
- Environmental Toxicology
- Forensic Toxicology
- Genetic Toxicology
- Immunotoxicology
- Molecular Toxicology
- Neurotoxicology
- Reproductive and Developmental Toxicology
- Systemic Toxicology
- Toxicity Testing`
- Toxicology and Risk Assessment (TRA)
- Toxicology study in Effects on Liver and Kidney
- Toxicology study in Haemostasis
- Toxicopathology
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinicalpharmacology2025 (Canada)
- Air and Water quality - TOXICOLOGY CONGRESS 2025 (France)
- Air pollution and Health - TOXICOLOGY CONGRESS 2025 (France)
- Cardiovascular Pharmacology - clinicalpharmacology2025 (Canada)
- Chemical Safety and Regulation - TOXICOLOGY CONGRESS 2025 (France)
- Climate Change and Health Effects - TOXICOLOGY CONGRESS 2025 (France)
- Clinical Toxicology of Drugs of Abuse - clinicalpharmacology2025 (Canada)
- Clinical Trials and Regulatory Affairs - clinicalpharmacology2025 (Canada)
- Drug Interactions and Polypharmacy - clinicalpharmacology2025 (Canada)
- Ecotoxicology - TOXICOLOGY CONGRESS 2025 (France)
- Emerging Contaminants - TOXICOLOGY CONGRESS 2025 (France)
- Emerging Trends in Clinical Pharmacology - clinicalpharmacology2025 (Canada)
- Environmental and Occupational Toxicology - clinicalpharmacology2025 (Canada)
- Environmental Contaminants - TOXICOLOGY CONGRESS 2025 (France)
- Environmental Health - TOXICOLOGY CONGRESS 2025 (France)
- Environmental Justice - TOXICOLOGY CONGRESS 2025 (France)
- Food Safety and Toxicants - TOXICOLOGY CONGRESS 2025 (France)
- Future Directions in Clinical Pharmacology and Toxicology - clinicalpharmacology2025 (Canada)
- Hazardous Waste Management - TOXICOLOGY CONGRESS 2025 (France)
- Industrial Toxicology - TOXICOLOGY CONGRESS 2025 (France)
- Innovations in Drug Development and Therapeutics - clinicalpharmacology2025 (Canada)
- Nanotoxicology - TOXICOLOGY CONGRESS 2025 (France)
- Natural Products and Toxicology - clinicalpharmacology2025 (Canada)
- Neuropharmacology and Toxicology - clinicalpharmacology2025 (Canada)
- Neurotoxicology - TOXICOLOGY CONGRESS 2025 (France)
- Occupational Health and Safety - TOXICOLOGY CONGRESS 2025 (France)
- Pediatric and Geriatric Pharmacology - clinicalpharmacology2025 (Canada)
- Pesticide Toxicology - TOXICOLOGY CONGRESS 2025 (France)
- Pharmacogenomics and Personalized Medicine - clinicalpharmacology2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - TOXICOLOGY CONGRESS 2025 (France)
- Pharmacokinetics and Pharmacodynamics - clinicalpharmacology2025 (Canada)
- Public Health Impacts - TOXICOLOGY CONGRESS 2025 (France)
- Radio Biology - TOXICOLOGY CONGRESS 2025 (France)
- Risk Assessment and Management - TOXICOLOGY CONGRESS 2025 (France)
- Toxicity Mechanisms - TOXICOLOGY CONGRESS 2025 (France)
- Toxicokinetics and Toxicodynamics - TOXICOLOGY CONGRESS 2025 (France)
- Toxicology - TOXICOLOGY CONGRESS 2025 (France)
- Toxicology and Risk Assessment - clinicalpharmacology2025 (Canada)